ZA982047B - Hiv protease inhibitors - Google Patents

Hiv protease inhibitors

Info

Publication number
ZA982047B
ZA982047B ZA982047A ZA982047A ZA982047B ZA 982047 B ZA982047 B ZA 982047B ZA 982047 A ZA982047 A ZA 982047A ZA 982047 A ZA982047 A ZA 982047A ZA 982047 B ZA982047 B ZA 982047B
Authority
ZA
South Africa
Prior art keywords
protease inhibitors
hiv protease
hiv
inhibitors
protease
Prior art date
Application number
ZA982047A
Other languages
English (en)
Inventor
Kim ALBIZATI
Siegfried Reich
Michael D Varney
Danyin E Zhang
Takuo Kobayashi
Original Assignee
Agouron Pharma
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma, Japan Tobacco Inc filed Critical Agouron Pharma
Publication of ZA982047B publication Critical patent/ZA982047B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA982047A 1997-03-13 1998-03-11 Hiv protease inhibitors ZA982047B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81595197A 1997-03-13 1997-03-13

Publications (1)

Publication Number Publication Date
ZA982047B true ZA982047B (en) 1998-09-28

Family

ID=25219265

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA982047A ZA982047B (en) 1997-03-13 1998-03-11 Hiv protease inhibitors

Country Status (35)

Country Link
EP (1) EP0970055A2 (cs)
JP (1) JP2001516350A (cs)
KR (1) KR100511089B1 (cs)
CN (1) CN1179948C (cs)
AP (1) AP1358A (cs)
AR (1) AR012556A1 (cs)
AU (1) AU743078B2 (cs)
BG (1) BG63540B1 (cs)
BR (1) BR9808867A (cs)
CA (1) CA2284163A1 (cs)
CO (1) CO4940496A1 (cs)
CZ (1) CZ296647B6 (cs)
EA (1) EA002378B1 (cs)
EE (1) EE04114B1 (cs)
GE (1) GEP20022764B (cs)
HR (1) HRP980112A2 (cs)
HU (1) HUP0001380A3 (cs)
IL (2) IL131870A0 (cs)
IS (1) IS5176A (cs)
MX (1) MXPA99008395A (cs)
MY (1) MY117535A (cs)
NO (1) NO315555B1 (cs)
NZ (1) NZ337706A (cs)
OA (1) OA11196A (cs)
PA (1) PA8448801A1 (cs)
PE (1) PE58799A1 (cs)
PL (1) PL192786B1 (cs)
SA (1) SA98181116B1 (cs)
SK (1) SK283636B6 (cs)
SV (1) SV1998000038A (cs)
TR (1) TR199902508T2 (cs)
TW (1) TW200517112A (cs)
UA (1) UA57772C2 (cs)
WO (1) WO1998040357A2 (cs)
ZA (1) ZA982047B (cs)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
HUP0001380A2 (hu) 2000-09-28
NO994415D0 (no) 1999-09-10
PL192786B1 (pl) 2006-12-29
CZ319199A3 (cs) 2000-06-14
JP2001516350A (ja) 2001-09-25
OA11196A (en) 2003-05-21
IL131870A0 (en) 2001-03-19
EE04114B1 (et) 2003-08-15
PE58799A1 (es) 1999-07-12
EA002378B1 (ru) 2002-04-25
IS5176A (is) 1999-09-10
AP9901648A0 (en) 1999-09-30
MXPA99008395A (es) 2003-08-12
AR012556A1 (es) 2000-11-08
PL335672A1 (en) 2000-05-08
BG103727A (en) 2000-04-28
BG63540B1 (bg) 2002-04-30
AU743078B2 (en) 2002-01-17
NZ337706A (en) 2001-04-27
SA98181116B1 (ar) 2006-10-04
WO1998040357A3 (en) 1998-11-26
KR20000076236A (ko) 2000-12-26
IL131870A (en) 2006-04-10
EA199900823A1 (ru) 2000-04-24
PA8448801A1 (es) 2000-05-24
NO315555B1 (no) 2003-09-22
EP0970055A2 (en) 2000-01-12
NO994415L (no) 1999-11-10
CA2284163A1 (en) 1998-09-17
GEP20022764B (en) 2002-08-26
CO4940496A1 (es) 2000-07-24
UA57772C2 (uk) 2003-07-15
HRP980112A2 (en) 1998-12-31
TW200517112A (en) 2005-06-01
BR9808867A (pt) 2000-07-11
CN1179948C (zh) 2004-12-15
MY117535A (en) 2004-07-31
TR199902508T2 (xx) 2000-02-21
CN1253548A (zh) 2000-05-17
SK283636B6 (sk) 2003-11-04
KR100511089B1 (ko) 2005-08-31
AP1358A (en) 2004-12-03
EE9900416A (et) 2000-04-17
AU6457598A (en) 1998-09-29
SK122299A3 (en) 2000-05-16
WO1998040357A2 (en) 1998-09-17
HUP0001380A3 (en) 2001-12-28
SV1998000038A (es) 1999-02-15
CZ296647B6 (cs) 2006-05-17

Similar Documents

Publication Publication Date Title
PL336625A1 (en) Protease inhibitors
PL336589A1 (en) Serinic protease inhibitors
ZA983762B (en) Protease inhibitors
PL337755A1 (en) Protease inhibitors
ZA983522B (en) Protease inhibitors
ZA988479B (en) Protease inhibitors
EP0691345A3 (en) Combinations of HIV protease inhibitors
AUPM982594A0 (en) HIV protease inhibitors
ZA988064B (en) Protease inhibitors
ZA984514B (en) Hiv protease inhibitor
IL132998A0 (en) Vif-derived hiv protease inhibitors
GB9815925D0 (en) HIV Intergrase inhibitors
EP0975612A4 (en) PROTEASE INHIBITORS
GB9704559D0 (en) Protease
IL131870A0 (en) Hiv protease inhibitors
GB9714320D0 (en) Hiv protease inhibitor
HU0900220D0 (en) Hiv protease inhibitors
ZA983097B (en) Protease inhibitors
PH31405A (en) Hiv protease inhibitors.
GB9716884D0 (en) Formulations for an HIV protease inhibitor
AU2002301207A1 (en) Antiviral protease inhibitors
SI0774969T1 (en) Hiv protease inhibitor combination
AU4111896A (en) Hiv protease inhibitors
GB9602851D0 (en) HIV intergrase inhibitors
GB9722761D0 (en) HIV intergrase inhibitors